Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	95.56	48.52	24.81
Graham Fair Price	-11.86	56.60	64.22
PEG	273.52	-0.69	0.18
Price/Book	37.02	8.32	6.07
Price/Cash Flow	371.98	98.19	20.80
Prices/Earnings	89.82	17.30	9.12
Price/Sales	95.29	11.08	5.67
Price/FCF	371.98	98.19	20.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.04	0.48	0.46
Operating Margin	-3.29	0.20	0.20
ROA	-23.40	0.05	0.07
ROE	0.17	0.12	-27.82
ROIC	0.10	0.07	-27.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	< 0.005	-1051.34
Dividends QOQ	< 0.005	0.08	19569.21
EBIT QOQ	0.46	-0.30	-35.59
EPS QOQ	0.49	-0.25	-49.18
FCF QOQ	1.50	-0.70	-53.44
Revenue QOQ	0.23	-0.27	18.31
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	91.17	127.83	40.21
Days Sales Outstanding (DSO)	4.85	6.25	28.66
Inventory Turnover	0.99	0.70	-28.68
Debt/Capitalization	0.40	0.38	-4.40
Quick Ratio	0.74	0.80	8.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.17	34.41	3.74
Cash	19.67	19.54	-0.67
Capex	-0.84	-0.62	26.39
Free Cash Flow	9.69	2.92	-69.88
Revenue	35.53	25.86	-27.22
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.45	1.55	7.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.24	0.23	-6.44
Naive Interpretation	Member

06 - Financial Health · Weak

Rating